Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: …
Read More »Postmenopausal Sex Hormone Levels Associated With Later CVD
Higher testosterone/estradiol ratio linked to elevated risk for incident cardiovascular disease
Read More »Male Thyroid Cancer Survivors Face Higher CVD Risk
Age at diagnosis, sex, BMI, and thyroid-stimulating hormone suppression therapy affect CVD risk
Read More »CVD Risk Up Even in Metabolically Healthy Obese Women
Women with metabolically unhealthy normal-weight, overweight, obesity had considerably higher risk
Read More »T1DM Self-Management Varies With Adult Developmental Stages
Mean HbA1c levels highest for emerging adults (age 18 to <25) and lowest for older adults (age ≥65)
Read More »Elevated HbA1c Usually Leads to Prompt Tx Start, Intensification
Within 6 months of elevated HbA1c, rate of initiation 63 percent, rate of intensification 82 percent
Read More »Mini-Dose Glucagon May Halt Post-Exercise Hypoglycemia
Appears to prevent exercise-induced hypoglycemia, reduce risk for hyperglycemia in T1DM patients
Read More »Hypofractionated Radiotherapy Best in Anaplastic Thyroid Cancer
Hypofractionated radiotherapy beats conventionally fractionated RT in orthotopic ATC model
Read More »Senior CA Patients Also Benefit From Palliative Radiotherapy
Benefit of palliative radiation for bone metastasis across age groups; older age should not preclude tx
Read More »Higher Seafood Intake May Shorten Time to Pregnancy
More than eight servings per cycle also tied to higher frequency of intercourse
Read More »